Extensive ongoing research across the Europe to identify new treatments for eye diseases is likely to favor the vision care market growth in the coming years. The institute also funds trials to develop cutting-edge therapies for blinding diseases. In 2017, the NEI launched a 3D Retina Organoid Challenge Competition (3D-ROC) to develop functioning mini-retinas from human stem cells. It announced the prize money of US$ 1.1 million to the team with the best replication of retina structure and function.
The Karolinska Institutet, Sweden, offers grants to promote research on eye diseases. In 2020, the institute announced SEK 50,000–150,000 (US$ 5,912.88–17,738.64) per person funding for new research projects on eye diseases. These funds will be used to provide maximum flexibility in developing and expanding eye research programs and fostering creative planning beyond the scope of restricted project grants. Thus, increasing funds for eyecare research are likely to bring new trends in the vision care market to trigger its growth.
The European vision care market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the vision care market. The European vision care market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing prevalence of eye disease and diabetes, launch of innovative products by market players in the region.
The Europe vision care market is segmented based on type, distribution channel, and country. Based on type, the Europe vision care market is segmented into eyeglasses, contact lens, intraocular lens, and others. The eyeglasses segment held the largest market share in 2022.
Based on distribution channel, the Europe vision care market is segmented into retail stores, e-commerce, clinics, and hospitals. The retail stores segment held the largest market share in 2022.
Based on country, the Europe vision care market is segmented into Germany, the UK, Spain, Italy, France, and the Rest of Europe. Germany dominated the Europe vision care market share in 2022.
Alcon Inc.; Bausch Health Companies Inc.; Carl Zeiss AG; Cooper Companies Inc; Essilor International SAS; Johnson & Johnson; Hoya Corp; Rodenstock GMBH; Menicon Co., Ltd; and Rayner Intraocular Lenses Limited are the leading companies operating in the Europe vision care market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 23,743.83 Million |
| Market Size by 2028 | US$ 31,199.09 Million |
| CAGR (2022 - 2028) | 4.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Vision Care Market is valued at US$ 23,743.83 Million in 2022, it is projected to reach US$ 31,199.09 Million by 2028.
As per our report Europe Vision Care Market, the market size is valued at US$ 23,743.83 Million in 2022, projecting it to reach US$ 31,199.09 Million by 2028. This translates to a CAGR of approximately 4.7% during the forecast period.
The Europe Vision Care Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Vision Care Market report:
The Europe Vision Care Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Vision Care Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Vision Care Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Vision Care Market
